162 related articles for article (PubMed ID: 29414413)
1. Generation of induced pluripotent stem cells from a Becker muscular dystrophy patient carrying a deletion of exons 45-55 of the dystrophin gene (CCMi002BMD-A-9 ∆45-55).
Gowran A; Spaltro G; Casalnuovo F; Vigorelli V; Spinelli P; Castiglioni E; Rovina D; Paganini S; Di Segni M; Gervasini C; Nigro P; Pompilio G
Stem Cell Res; 2018 Apr; 28():21-24. PubMed ID: 29414413
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line carrying a deletion of exons 51-53 of the dystrophin gene (CCMi003-A).
Rovina D; Castiglioni E; Farini A; Bellichi M; Gervasini C; Paganini S; Di Segni M; Santoro R; Torrente Y; Pompilio G; Gowran A
Stem Cell Res; 2019 Oct; 40():101544. PubMed ID: 31465894
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming of dermal fibroblasts from a Duchenne muscular dystrophy patient carrying a deletion of exons 45-50 into an induced pluripotent stem cell line (CCMi005-A).
Rovina D; Castiglioni E; Mallia S; Rabino M; Farini A; Belicchi M; Di Giuseppe G; Gervasini C; Torrente Y; Pompilio G; Gowran A
Stem Cell Res; 2022 Oct; 64():102889. PubMed ID: 35961103
[TBL] [Abstract][Full Text] [Related]
4. Generation of Duchenne muscular dystrophy patient-specific induced pluripotent stem cell line lacking exons 45-50 of the dystrophin gene (IITi001-A).
Eisen B; Ben Jehuda R; Cuttitta AJ; Mekies LN; Reiter I; Ramchandren S; Arad M; Michele DE; Binah O
Stem Cell Res; 2018 May; 29():111-114. PubMed ID: 29653394
[TBL] [Abstract][Full Text] [Related]
5. Derivation of the Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line lacking DMD exons 49 and 50 (CCMi001DMD-A-3, ∆49, ∆50).
Spaltro G; Vigorelli V; Casalnuovo F; Spinelli P; Castiglioni E; Rovina D; Paganini S; Di Segni M; Nigro P; Gervasini C; Pompilio G; Gowran A
Stem Cell Res; 2017 Dec; 25():128-131. PubMed ID: 29127875
[TBL] [Abstract][Full Text] [Related]
6. Generation of the Becker muscular dystrophy patient derived induced pluripotent stem cell line carrying the DMD splicing mutation c.1705-8 T>C.
Rovina D; Castiglioni E; Niro F; Farini A; Belicchi M; Di Fede E; Gervasini C; Paganini S; Di Segni M; Torrente Y; Santoro R; Pompilio G; Gowran A
Stem Cell Res; 2020 May; 45():101819. PubMed ID: 32348941
[TBL] [Abstract][Full Text] [Related]
7. Becker muscular dystrophy severity is linked to the structure of dystrophin.
Nicolas A; Raguénès-Nicol C; Ben Yaou R; Ameziane-Le Hir S; Chéron A; Vié V; Claustres M; Leturcq F; Delalande O; Hubert JF; Tuffery-Giraud S; Giudice E; Le Rumeur E;
Hum Mol Genet; 2015 Mar; 24(5):1267-79. PubMed ID: 25348330
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a human iPSC line XMDYYYi001-A from a patient with Becker muscular dystrophy harboring duplications of exons 2-19 in dystrophin gene.
Wang D; Lin J; Jin M; Wang N
Stem Cell Res; 2021 May; 53():102298. PubMed ID: 33799273
[TBL] [Abstract][Full Text] [Related]
9. Asymptomatic Becker muscular dystrophy in a family with a multiexon deletion.
Ferreiro V; Giliberto F; Muñiz GM; Francipane L; Marzese DM; Mampel A; Roqué M; Frechtel GD; Szijan I
Muscle Nerve; 2009 Feb; 39(2):239-43. PubMed ID: 19012301
[TBL] [Abstract][Full Text] [Related]
10. Duchenne and Becker muscular dystrophy: a molecular and immunohistochemical approach.
Freund AA; Scola RH; Arndt RC; Lorenzoni PJ; Kay CK; Werneck LC
Arq Neuropsiquiatr; 2007 Mar; 65(1):73-6. PubMed ID: 17420831
[TBL] [Abstract][Full Text] [Related]
11. Homozygous female Becker muscular dystrophy.
Fujii K; Minami N; Hayashi Y; Nishino I; Nonaka I; Tanabe Y; Takanashi J; Kohno Y
Am J Med Genet A; 2009 May; 149A(5):1052-5. PubMed ID: 19396825
[TBL] [Abstract][Full Text] [Related]
12. Becker muscular dystrophy in Indian patients: analysis of dystrophin gene deletion patterns.
Dastur RS; Gaitonde PS; Khadilkar SV; Nadkarni JJ
Neurol India; 2008; 56(3):374-8. PubMed ID: 18974567
[TBL] [Abstract][Full Text] [Related]
13. Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.
Toh ZY; Thandar Aung-Htut M; Pinniger G; Adams AM; Krishnaswarmy S; Wong BL; Fletcher S; Wilton SD
PLoS One; 2016; 11(1):e0145620. PubMed ID: 26745801
[TBL] [Abstract][Full Text] [Related]
14. Generation of human induced pluripotent stem cell line derived from Becker muscular dystrophy patient with CRISPR/Cas9-mediated correction of DMD gene mutation.
Przymuszała M; Martyniak A; Kwiatkowska J; Meyer-Szary J; Śledzińska K; Wierzba J; Dulak J; Florczyk-Soluch U; Stępniewski J
Stem Cell Res; 2024 Apr; 76():103327. PubMed ID: 38324931
[TBL] [Abstract][Full Text] [Related]
15. Targeted addition of mini-dystrophin into rDNA locus of Duchenne muscular dystrophy patient-derived iPSCs.
Zeng B; Zhou M; Liu B; Shen F; Xiao R; Su J; Hu Z; Zhang Y; Gu A; Wu L; Liu X; Liang D
Biochem Biophys Res Commun; 2021 Mar; 545():40-45. PubMed ID: 33540285
[TBL] [Abstract][Full Text] [Related]
16. Deletion of exon 26 of the dystrophin gene is associated with a mild Becker muscular dystrophy phenotype.
Witting N; Duno M; Vissing J
Acta Myol; 2011 Dec; 30(3):182-4. PubMed ID: 22616200
[TBL] [Abstract][Full Text] [Related]
17. Late onset and very mild course of Xp21 Becker type muscular dystrophy.
Bosone I; Bortolotto S; Mongini T; Doriguzzi C; Chiadò-Piat L; Ugo I; Mutani R; Palmucci L
Clin Neuropathol; 2001; 20(5):196-9. PubMed ID: 11594504
[TBL] [Abstract][Full Text] [Related]
18. Characterization of deletion breakpoints in patients with dystrophinopathy carrying a deletion of exons 45-55 of the Duchenne muscular dystrophy (DMD) gene.
Miyazaki D; Yoshida K; Fukushima K; Nakamura A; Suzuki K; Sato T; Takeda S; Ikeda S
J Hum Genet; 2009 Feb; 54(2):127-30. PubMed ID: 19158820
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of the dystrophin gene in children with Duchenne and Becker muscular dystrophies.
Zhong J; Xu T; Chen G; Liao H; Zhang J; Lan D
Muscle Nerve; 2017 Jul; 56(1):117-121. PubMed ID: 27750387
[TBL] [Abstract][Full Text] [Related]
20. Generation of two Duchenne muscular dystrophy patient-specific induced pluripotent stem cell lines DMD02 and DMD03 (MUNIi001-A and MUNIi003-A).
Jelinkova S; Markova L; Pesl M; Valáškova I; Makaturová E; Jurikova L; Vondracek P; Lacampagne A; Dvorak P; Meli AC; Rotrekl V
Stem Cell Res; 2019 Oct; 40():101562. PubMed ID: 31526943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
